Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now official registry

Acne clinical trials

Every US clinical trial registered for Acne — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.

27 US clinical trials · 6 currently recruiting

The research picture

Acne has 27 registered US clinical trials, 6 of them open to new participants right now — about 22% of the total.

6
recruiting participants now
22%
of trials open to enrollment
9
in Phase 3–4 (later-stage)
4
top sponsor: Galderma R&D

Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.

Active & Recent Trials

RECRUITING Phase 1 260 participants

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Sanofi Pasteur, a Sanofi Company

NCT06316297

RECRUITING NA 200 participants

AVAVA MIRIA General Use

AVAVA

NCT06868615

RECRUITING NA 150 participants

The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis

Integrative Skin Science and Research

NCT05942248

RECRUITING Phase 1 128 participants

Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne

Sagimet Biosciences

NCT06989840

RECRUITING Phase 1 120 participants

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne

Sanofi Pasteur, a Sanofi Company

NCT07013747

RECRUITING NA 10 participants

Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production

Austin Institute for Clinical Research

NCT06376110

ACTIVE NOT RECRUITING NA 500 participants

Clinical Study to Evaluate the Safety and Efficacy of Candela Technology

Candela Corporation

NCT06202274

ACTIVE NOT RECRUITING Phase 4 350 participants

Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne

University of Pennsylvania

NCT04582383

ACTIVE NOT RECRUITING Early Phase 1 72 participants

Experience With Topical Acne Treatment

Wake Forest University Health Sciences

NCT05582434

COMPLETED Phase 3 1,001 participants

Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris

Actavis

NCT02651220

COMPLETED Phase 4 128 participants

Comparison Study of Topical Acne Regimens

MedDerm Associates

NCT00913185

COMPLETED Phase 4 127 participants

A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments

Galderma R&D

NCT02755545

COMPLETED NA 102 participants

RCT of an Oral Acne Supplement for Adult Women

Nutraceutical Wellness

NCT06097871

COMPLETED Phase 4 81 participants

Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris

Galderma R&D

NCT01951417

COMPLETED Phase 2 73 participants

Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne

Galderma R&D

NCT01106807

COMPLETED NA 63 participants

Joovvin' for Your Skin Health Study

ProofPilot

NCT04471896

COMPLETED Phase 4 61 participants

Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%

Galderma R&D

NCT00437151

COMPLETED 59 participants

Sleep, Circadian Rhythm & Skin Health

University Hospitals Cleveland Medical Center

NCT02457000

COMPLETED NA 38 participants

An Exploratory Investigation of a Male Focused Skincare Supplement

Let's Dis

NCT05319847

COMPLETED NA 38 participants

An Exploratory Investigation of a Novel Skincare Regimen

Trophy Skin

NCT05517720

COMPLETED NA 30 participants

Study Evaluating the Efficacy and Safety of TheraClearX on Mitigating Mild to Moderate Acne

Ablon Skin Institute Research Center

NCT06043102

COMPLETED Phase 4 25 participants

Profiling the Skin Microbiome in Response to Altreno in Acne Patients

Beth Israel Deaconess Medical Center

NCT04548349

COMPLETED NA 22 participants

The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation

Integrative Skin Science and Research

NCT06080035

COMPLETED Phase 4 20 participants

Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris

Derm Research, P

NCT02944461

COMPLETED Phase 1 20 participants

Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel

Bausch Health Americas

NCT02850003

COMPLETED 15 participants

Comparison of Stacked-Pulses Vs. Double-Pass Treatments of Facial Acne With a 1450 Nm Laser

Skincare Physicians of Chestnut Hill

NCT00306371

COMPLETED Phase 4 12 participants

Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline

BioPharmX

NCT02695446

Phase Distribution

PhaseTrial count
Phase 1 5
Phase 2 1
Phase 3 1
Phase 4 8

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Acne Trial Landscape

ClinicalTrials.gov lists 27 US studies indexed under Acne, and 6 of those are currently open to recruitment — roughly 22% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Acne shows 9 late-stage studies (Phase 3 and Phase 4 combined) alongside 6 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Acne is led by Galderma R&D with 4 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 27 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Acne?

PlainTrial tracks 27 US clinical trials for Acne, of which 6 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Acne?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →